Clinical Immunology Stp

[Athina Dollison]

The Division of Clinical Immunology is the largest provider of allergy care in New York City. In addition to providing comprehensive evaluations for allergic disorders, our providers are recognized nationally for their expertise in the evaluation and treatment of asthma, atopic dermatitis, hereditary angioedema (HAE), and urticaria (hives). Full testing is available, and may include allergy skin tests, pulmonary function tests, diagnostic food and drug challenges, and patch tests. Therapies include allergy immunotherapy and rush immunotherapy. This devotion to best clinical practices complements our innovative allergy research programs. Our approach to all patients is multi-disciplinary, compassionate care and the practice of personalized state-of-the-art medicine.

Finally, this Division remains devoted to the training of the next generation of leaders in Allergy and Immunology including physicians and scientists through our fellowship and mentoring programs. The Division continues to engage in Quality Improvement programs.

The Division of Clinical Immunology conducts basic, translational and clinical research aimed at understanding the complex interplay of molecules, cells, tissues, and organs that mobilize to overcome invaders.

Rachel Miler, MD, is Chief of the Division of Clinical Immunology, the Dr. David and Dorothy Merksamer Professor of Medicine (Allergy and Immunology) and Professor of Environmental Medicine and Public Health. Read more

Journal of Clinical Immunology is an international journal that focuses on human immunology, particularly primary immunodeficiencies and related diseases.

• Publishes high impact papers exploring diagnosis, pathogenesis, prognosis, or treatment of human diseases.
• Considers a wide range of studies, from genetic discovery and clinical description to immunologic assessment, diagnostic approach, prognosis evaluation, and treatment intervention.
• In the top 25% of qualifying journals for editorial excellence.
• High level of author satisfaction with 100% of authors reporting they would publish with us again.
• Case reports of general significance are also considered.

Our faculty, staff, and trainees play an exceptionally critical role in shaping the future of healthcare through their expertise in education, research, and clinical practice, driving innovation and excellence.

FOCIS engages with the global and Ukrainian translational immunology academic and scientific research community, and we endorse the International Science Council (ISC) Statement on Ukraine.

We at FOCIS are working to support our Member Society in Ukraine, the Ukrainian Society of Specialists in Immunology, Allergology and Immunorehabilitation (UTIAI), through this difficult situation to provide the means to continue sharing research and collaborate in the translational immunology community. One way that we can all help is to consider donating to organizations committed to providing humanitarian aid, including the International Committee of the Red Cross, Refugees International, and other similar non-governmental humanitarian organizations.

As the people and nation of Ukraine courageously defend its borders and sovereignty, we deplore the lives lost and the threat to the human rights of all people involved in this terrible struggle. Our thoughts are with our friends, colleagues, and all who have been impacted. We fervently hope for a swift end to this war and the restoration of peace and safety to Ukraine and the surrounding region.

Due to the competition for places and high quality of applications that we receive, we give preference to applicants with grades above our minimum entry requirements and who can demonstrate relevant experience in immunology.

All fees for entry will be subject to yearly review and incremental rises per annum are also likely over the duration of courses lasting more than a year for UK/EU students (fees are typically fixed for international students for the course duration at the year of entry).

All students should normally be able to complete their programme of study without incurring additional study costs over and above the tuition fee for that programme. Any unavoidable additional compulsory costs totalling more than 1% of the annual home undergraduate fee per annum, regardless of whether the programme in question is undergraduate or postgraduate taught, will be made clear to you at the point of application. Further information can be found in the University's Policy on additional costs incurred by students on undergraduate and postgraduate taught programmes (PDF document, 91KB).

Our mission is to serve patients through our clinical endeavors while training the most excellent Allergists and Immunologists who will practice our specialty, conduct research, and go on to teach subsequent generations of outstanding physicians in the field. We strive to:

Our fellows will benefit from learning about the many facets of the practice of medicine, including sensitivity and compassion for the human beings they see in their practice, awareness of cultural differences, and the ethical practice of medicine. They will be exposed to many related topics, basic science and clinical, through our various seminars and conferences. Our fellows participate in ongoing research and must choose a research project to complete and present for completion of their training. Our fellows, through their training, develop a lifelong interest and desire to continue learning and to share their knowledge.

Congratulations to Dr. Laurianne Wild and Dr. Jane El-Dahr, both of who were chosen as among the best Allergy and Immunology physicians in the state of Louisiana by Best Doctors, Inc., a company that has built a database of professionals that are highly regarded by their peers. For a complete list, visit the Louisiana Life Magazine website.

Our Allergy and Immunology fellowship program is committed to equity as the driver of diversity and inclusion (EDI). Tulane defines diversity broadly to include persons of color, members of the LGBTQIA community, members of diverse ethnic groups, including those typically underrepresented in medicine, members of economically disadvantaged groups, and any others who bring a different perspective to the learning environment. We in Allergy and Immunology are committed to providing excellent, patient-centered care to our diverse patient population. We provide care at several locations that include underrepresented minorities and other economically disadvantaged groups. We also take pride in having a group of providers and trainees made up of persons from ethnically diverse backgrounds, including members of color and members from the LGBTQIA community. Having individual providers and learners from these diverse groups helps us provide better care to our diverse patient population and better education through connection, understanding, and appreciation of our unique differences. Equity, Diversity, and Inclusion = Excellence in patient care and learning!

Primary immunodeficiencies (PIDs) that arise from a variety of mutations in genes involved in the immune system are a major focus area of the laboratory. To develop a comprehensive understanding of the natural history and pathogenesis of PIDs, the LCIM integrates clinical studies with laboratory investigations at molecular-, cellular-, and systems-level scales. Through exploiting knowledge gained in the clinic and in the laboratory, the LCIM aims to develop novel diagnostic methods and therapeutic approaches to manage and, ideally, cure patients of PIDs and infectious diseases.

Clinical and basic science aspects of bacterial, fungal, and viral microbiology and pathogenesis are another major concentration of LCIM investigators. Vaccine development and drug discovery efforts have led to several international clinical trials that aim to lessen the global impact of microbial diseases and prevent or minimize the emergence of drug-resistant microbes.

Training of physicians and scientists is central to the LCIM mission. The NIAID Infectious Disease Fellowship Training Program, the NIAID Primary Immune Deficiency Clinic, and the NIH Clinical Center Infectious Disease Consultation Service are integral components of the LCIM and facilitate the reciprocal education of basic scientists and clinical fellows alike.

The NIAID Primary Immune Deficiency (PID) Clinic is located at the National Institutes of Health (NIH) Clinical Center. The clinic accepts patients who are at least 2 years old who have a known or suspected primary immune deficiency disease.

NIAID offers a three- to four-year, ACGME-accredited, clinical and research fellowship program for those interested in pursuing academic careers in infectious diseases that develops outstanding clinical and research skills in physicians who are already well rounded in clinical medicine.

The Division of Clinical Immunology and Allergy combines innovative treatment, research, education and outreach in the care of children with severe allergic disease, asthma, primary immune deficiency disorders and HIV/AIDS.

The Atopic Dermatitis Program in the Division of Clinical Immunology and Allergy at Children's Hospital Los Angeles emphasizes proactive medical and psychosocial interventions for atopic dermatitis or eczema. Patients with moderate to severe atopic dermatitis may experience chronic infections, irritation, embarassment. Our staff educates the patients and parents how to care and control the disease.

New patients are evaluated for atopic dermatitis triggers, which may include infections, food allergies and inhalant allergens. Tests provided include standard skin testing, RAST testing and food challenges.

Atopic dermatitis is very common; however, there is no cure, so our staff understands the frustrations the patient goes through. We work with patients and parents to determine a care plan to help improve their quality of life. Treatments such as bathing, prescriptions, ointments and other options will help descrease the urges to itch or scratch the irritated skin.

c80f0f1006